[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Arm A Best supportive care with Itolizumab: Start at 1.6 mg/kg dose iv infusion; if well tolerated and improvement in patient observed; investigator has the discretion to continue with 1.6 mg/kg dose every 2 weeks or 0.8 mg/kg weekly regimen.Control Intervention1: Arm B Best supportive care: By best supportive care\u00e2?? which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy; will be administered. The best supportive care will be as per institution standard", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Arm A Best supportive care with Itolizumab: Start at 1.6 mg/kg dose iv infusion; if well tolerated and improvement in patient observed; investigator has the discretion to continue with 1.6 mg/kg dose every 2 weeks or 0.8 mg/kg weekly regimen.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Arm B Best supportive care: By best supportive care\u00e2?? which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy; will be administered. The best supportive care will be as per institution standard", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 691, "treatment_name": "Itolizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Arm A Best supportive care with Itolizumab: Start at 1.6 mg/kg dose iv infusion; if well tolerated and improvement in patient observed; investigator has the discretion to continue with 1.6 mg/kg dose every 2 weeks or 0.8 mg/kg weekly regimen.Control Intervention1: Arm B Best supportive care: By best supportive care\u00e2?? which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy; will be administered. The best supportive care will be as per institution standard", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Arm A Best supportive care with Itolizumab: Start at 1.6 mg/kg dose iv infusion; if well tolerated and improvement in patient observed; investigator has the discretion to continue with 1.6 mg/kg dose every 2 weeks or 0.8 mg/kg weekly regimen.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Arm B Best supportive care: By best supportive care\u00e2?? which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy; will be administered. The best supportive care will be as per institution standard", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]